DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Gujarat Themis Biosyn Limited — Board Meeting Intimation

NSE 1 hr ago·27 Oct 2026, 6:57 am

Gujarat Themis Biosyn

Gujarat Themis Biosyn Limited has announced that its board will meet on November 4, 2026, to review and approve the company's unaudited financial results for the half-yearly period ending September 2026.

This update is a routine corporate disclosure, but it is significant for investors as it provides an early glimpse into the company's financial performance. The results will reveal whether the company's business operations are on track to meet its targets and if there are any emerging trends in its revenue or profitability.

Investors should monitor the market reaction to this announcement. The stock's movement will likely depend on the company's operational health and future growth outlook, which will be detailed in the official results.